These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

323 related articles for article (PubMed ID: 24798623)

  • 61. Hepatopulmonary syndrome: update on recent advances in pathophysiology, investigation, and treatment.
    Grace JA; Angus PW
    J Gastroenterol Hepatol; 2013 Feb; 28(2):213-9. PubMed ID: 23190201
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Elevated von Willebrand factor antigen is an early plasma predictor of acute lung injury in nonpulmonary sepsis syndrome.
    Rubin DB; Wiener-Kronish JP; Murray JF; Green DR; Turner J; Luce JM; Montgomery AB; Marks JD; Matthay MA
    J Clin Invest; 1990 Aug; 86(2):474-80. PubMed ID: 2384595
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Acquired von Willebrand syndrome in patients with an axial flow left ventricular assist device.
    Meyer AL; Malehsa D; Bara C; Budde U; Slaughter MS; Haverich A; Strueber M
    Circ Heart Fail; 2010 Nov; 3(6):675-81. PubMed ID: 20739614
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Systemic clotting activation by low-grade endotoxaemia in liver cirrhosis: a potential role for endothelial procoagulant activation.
    Ferro D; Basili S; Lattuada A; Mantovani B; Bellomo A; Mannucci PM; Violi F
    Ital J Gastroenterol Hepatol; 1997 Oct; 29(5):434-40. PubMed ID: 9494853
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Enhanced processing of von Willebrand factor reflects disease severity and discriminates severe portal hypertension in cirrhosis.
    Langholm LL; Manon-Jensen T; Karsdal MA; Bendtsen F; Leeming DJ; Møller S
    Eur J Gastroenterol Hepatol; 2019 Aug; 31(8):1040-1048. PubMed ID: 30768435
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Hepatopulmonary syndrome in children with cirrhotic and non-cirrhotic portal hypertension: a single-center experience.
    Sari S; Oguz D; Sucak T; Dalgic B; Atasever T
    Dig Dis Sci; 2012 Jan; 57(1):175-81. PubMed ID: 21792618
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Hepatopulmonary syndrome.
    Machicao VI; Fallon MB
    Semin Respir Crit Care Med; 2012 Feb; 33(1):11-6. PubMed ID: 22447256
    [TBL] [Abstract][Full Text] [Related]  

  • 68. von Willebrand factor and its propeptide: the influence of secretion and clearance on protein levels and the risk of venous thrombosis.
    Nossent AY; VAN Marion V; VAN Tilburg NH; Rosendaal FR; Bertina RM; VAN Mourik JA; Eikenboom HC
    J Thromb Haemost; 2006 Dec; 4(12):2556-62. PubMed ID: 17059421
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Cardiac index and hepatopulmonary syndrome in liver transplantation candidates: The pulmonary vascular complications of liver disease study.
    DuBrock HM; Forde K; Krok K; Patel M; Al-Naamani N; Lin G; Oh JK; Fallon MB; Kawut SM; Krowka MJ
    Liver Transpl; 2023 May; 29(5):467-475. PubMed ID: 36862505
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Circulating Von Willebrand factor and high molecular weight multimers as markers of endothelial injury predict COVID-19 in-hospital mortality.
    Philippe A; Chocron R; Gendron N; Bory O; Beauvais A; Peron N; Khider L; Guerin CL; Goudot G; Levasseur F; Peronino C; Duchemin J; Brichet J; Sourdeau E; Desvard F; Bertil S; Pene F; Cheurfa C; Szwebel TA; Planquette B; Rivet N; Jourdi G; Hauw-Berlemont C; Hermann B; Gaussem P; Mirault T; Terrier B; Sanchez O; Diehl JL; Fontenay M; Smadja DM
    Angiogenesis; 2021 Aug; 24(3):505-517. PubMed ID: 33449299
    [TBL] [Abstract][Full Text] [Related]  

  • 71. [Hepato-pulmonary syndrome].
    Bozomitu L; Moraru E; Stana B; Burlea M; Aprodu G; Moraru D
    Rev Med Chir Soc Med Nat Iasi; 2010; 114(3):625-32. PubMed ID: 21243785
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Hepatopulmonary syndrome is related to the development of acute-on-chronic liver failure and poor prognosis in cirrhotic patients.
    Han SK; Kim MY; Kang SH; Suk KT; Baik SK
    Hepatol Int; 2021 Oct; 15(5):1207-1214. PubMed ID: 34319553
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Are the spider angiomas skin markers of hepatopulmonary syndrome?
    Silvério Ade O; Guimarães DC; Elias LF; Milanez EO; Naves S
    Arq Gastroenterol; 2013; 50(3):175-9. PubMed ID: 24322187
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Genetic risk factors for hepatopulmonary syndrome in patients with advanced liver disease.
    Roberts KE; Kawut SM; Krowka MJ; Brown RS; Trotter JF; Shah V; Peter I; Tighiouart H; Mitra N; Handorf E; Knowles JA; Zacks S; Fallon MB;
    Gastroenterology; 2010 Jul; 139(1):130-9.e24. PubMed ID: 20346360
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Tissue factor pathway inhibitor and von Willebrand factor antigen levels in adult respiratory distress syndrome and in a primate model of sepsis.
    Sabharwal AK; Bajaj SP; Ameri A; Tricomi SM; Hyers TM; Dahms TE; Taylor FB; Bajaj MS
    Am J Respir Crit Care Med; 1995 Mar; 151(3 Pt 1):758-67. PubMed ID: 7881667
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Persistently elevated levels of von Willebrand factor antigen in HIV infection. Downregulation during highly active antiretroviral therapy.
    Aukrust P; Bjørnsen S; Lunden B; Otterdal K; Ng EC; Ameln W; Ueland T; Müller F; Solum NO; Brosstad F; Frøland SS
    Thromb Haemost; 2000 Aug; 84(2):183-7. PubMed ID: 10959687
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Systematic review: role of elevated plasma von-Willebrand factor as predictor of mortality in patients with chronic liver disease.
    Eidelberg A; Kirubakaran R; Nair SC; Eapen CE; Elias E; Goel A
    Eur J Gastroenterol Hepatol; 2019 Oct; 31(10):1184-1191. PubMed ID: 31498279
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Hepatopulmonary Syndrome in children: a comparative study of non-cirrhotic vs. cirrhotic portal hypertension.
    Borkar VV; Poddar U; Kapoor A; Ns S; Srivastava A; Yachha SK
    Liver Int; 2015 Jun; 35(6):1665-72. PubMed ID: 25351435
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Parenchymal alterations in cirrhotic livers in patients with hepatopulmonary syndrome or portopulmonary hypertension.
    Ma C; Crippin JS; Chapman WC; Korenblat K; Vachharajani N; Gunter KL; Brunt EM
    Liver Transpl; 2013 Jul; 19(7):741-50. PubMed ID: 23463612
    [TBL] [Abstract][Full Text] [Related]  

  • 80. [Hepatopulmonary syndrome in patients with advanced hepatic disease: study of a series of 24 cases].
    Márquez Martín E; Jara Palomares L; Ortega Ruiz F; Grilo Bensusán I; López-Campos JL; Cejudo Ramos P; Pascasio JM; Rodríguez Becerra E
    Med Clin (Barc); 2008 Feb; 130(3):98-102. PubMed ID: 18261381
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.